Beam Therapeutics Inc. — Director's Dealing 2020

Feb 6, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Beam Therapeutics Inc. (BEAM)
CIK: 0001745999
Period of Report: 2020-02-05

Reporting Person: FMR LLC (10% Owner, See Remark 1)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series B Convertible Preferred Stock	$		Common Stock (66369)		Indirect
Series A-2 Convertible Preferred Stock	$		Common Stock (4715723)		Indirect
Series A-1 Convertible Preferred Stock	$		Common Stock (2189820)		Indirect

Footnotes

F1: The Series A-1, A-2, and B Convertible Preferred Stock are convertible on a 1-for-4.4843 basis into the number of shares of Common Stock as shown in column 3 at any time at the holder's election, and automatically upon the closing of the Issuer's initial public offering without payment or further consideration, and have no expiration date.